Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CHK1 (SRA737)/PARPi combination methods of inhibiting tumor growth

CHK1 (SRA737)/PARPi combination methods of inhibiting tumor growth

US Patent 11596637 · Granted Mar 7, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Replication stress pathway agent compositions and methods for treating cancer2025
Replication stress pathway agent compositions and methods for treating cancer2025
Replication stress pathway agent compositions and methods for treating cancer2023
Replication stress pathway agent compositions and methods for treating cancer2023
Replication stress pathway agent compositions and methods for treating cancer2023
Replication stress pathway agent compositions and methods for treating cancer2023
Class II human histone deacetylases, and uses related thereto2014
Class II human histone deacetylases, and uses related thereto2013
Histone deacetylases, and uses related thereto2013
Histone deacetylases, and uses related thereto2013
Histone deacetylases, and uses related thereto2013
Histone deacetylases, and uses related thereto2012